References
Younossi ZM, Page S, Rafiq N, et al. A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis. Obes Surg. 2011;21:431–9.
Yilmaz Y, Ulukaya E. Toward a biochemical diagnosis of NASH: insights from pathophysiology for distinguishing simple steatosis from steatohepatitis. Curr Med Chem. 2011;18:725–32.
Yilmaz Y, Kedrah AE, Ozdogan O. Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis. World J Gastroenterol. 2009;15:4387–91.
Muzzillo DA, Imoto M, Fukuda Y, et al. Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases. J Gastroenterol Hepatol. 1993;8:437–41.
Conflicts of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yilmaz, Y., Kurt, R. & Eren, F. Multimarker Strategies for Detecting NASH and NASH-Related Fibrosis: Promises and Caveats. OBES SURG 21, 1316–1317 (2011). https://doi.org/10.1007/s11695-011-0464-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-011-0464-4